HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Summer’s Eve Line Leads Prestige Brands' Growth On Former Fleet Products

This article was originally published in The Rose Sheet

Executive Summary

Market-leading feminine cleansing and douche brand and other products added in Prestige Brands' 2017 acquisition of CB Fleet helped drive its North American OTC health care revenues up 6.6% to $212.1m in its fiscal 2018 fourth quarter. Full-year revenues for the division in North America grew 20.5% to $868.9m fueled by the addition of the Fleet business and consumption growth in the firm’s core OTC brands, Prestige Brands said.

You may also be interested in...



Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning

Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.

Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning

Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.

Feminine Cleanser Marketing Never Without Challenges; Now The Category Has FDA’s Attention

FDA is investigating use of certain ingredients in feminine cleansing and hygiene products, according to its fiscal 2019 budget justification. The agency’s work could draw unfavorable attention to a category that already comes under fire regularly for alleged body shaming and disproportionate ill effects on women of color, among other accusations.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS121617

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel